[go: up one dir, main page]

WO1998013007A8 - Methods and compositions for lipidization of hydrophilic molecules - Google Patents

Methods and compositions for lipidization of hydrophilic molecules

Info

Publication number
WO1998013007A8
WO1998013007A8 PCT/US1997/017282 US9717282W WO9813007A8 WO 1998013007 A8 WO1998013007 A8 WO 1998013007A8 US 9717282 W US9717282 W US 9717282W WO 9813007 A8 WO9813007 A8 WO 9813007A8
Authority
WO
WIPO (PCT)
Prior art keywords
compounds
disulfide
fatty acid
lipidization
compositions
Prior art date
Application number
PCT/US1997/017282
Other languages
French (fr)
Other versions
WO1998013007A9 (en
WO1998013007A2 (en
Inventor
Wei-Chiang Shen
Jinghua Wang
Original Assignee
Univ Southern California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Southern California filed Critical Univ Southern California
Priority to IL12917797A priority Critical patent/IL129177A0/en
Priority to BR9712128-2A priority patent/BR9712128A/en
Priority to AU45967/97A priority patent/AU737865B2/en
Priority to EP97944483A priority patent/EP1023316A4/en
Priority to JP51593398A priority patent/JP2002515883A/en
Priority to CA002267179A priority patent/CA2267179A1/en
Publication of WO1998013007A2 publication Critical patent/WO1998013007A2/en
Publication of WO1998013007A9 publication Critical patent/WO1998013007A9/en
Priority to NO991465A priority patent/NO991465L/en
Publication of WO1998013007A8 publication Critical patent/WO1998013007A8/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Fatty acid derivatives of disulfide-containing compounds (for example, disulfide-containing peptides or proteins) comprising fatty acid-conjugated products with a disulfide linkage are employed for delivery of the compounds to mammalian cells. This modification markedly increases the absorption of the compounds by mammalian cells relative to the rate of absorption of the unconjugated compounds, as well as prolonging blood and tissue retention of the compounds. Moreover, the disulfide linkage in the conjugate is quite labile in vivo and thus facilitates intracellular or extracellular release of the intact compounds from the fatty acid moieties.
PCT/US1997/017282 1996-09-26 1997-09-26 Methods and compositions for lipidization of hydrophilic molecules WO1998013007A2 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IL12917797A IL129177A0 (en) 1996-09-26 1997-09-26 Methods and compositions for lipidization of hydrophilic molecules
BR9712128-2A BR9712128A (en) 1996-09-26 1997-09-26 Methods and compositions for lipidization of hydrophilic molecules
AU45967/97A AU737865B2 (en) 1996-09-26 1997-09-26 Methods and compositions for lipidization of hydrophilic molecules
EP97944483A EP1023316A4 (en) 1996-09-26 1997-09-26 METHODS AND COMPOSITIONS FOR THE LIPIDATION OF HYDROPHILIC MOLECULES
JP51593398A JP2002515883A (en) 1996-09-26 1997-09-26 Methods and compositions for lipidation of hydrophilic molecules
CA002267179A CA2267179A1 (en) 1996-09-26 1997-09-26 Methods and compositions for lipidization of hydrophilic molecules
NO991465A NO991465L (en) 1996-09-26 1999-03-25 Methods and Preparations for Lipidization of Hydrophilic Molecules

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US72130696A 1996-09-26 1996-09-26
US08/721,306 1996-09-26
US4949997P 1997-06-13 1997-06-13
US60/049,499 1997-06-13

Publications (3)

Publication Number Publication Date
WO1998013007A2 WO1998013007A2 (en) 1998-04-02
WO1998013007A9 WO1998013007A9 (en) 1998-08-13
WO1998013007A8 true WO1998013007A8 (en) 1999-05-20

Family

ID=26727231

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/017282 WO1998013007A2 (en) 1996-09-26 1997-09-26 Methods and compositions for lipidization of hydrophilic molecules

Country Status (10)

Country Link
EP (1) EP1023316A4 (en)
JP (1) JP2002515883A (en)
KR (1) KR100691315B1 (en)
CN (1) CN1127477C (en)
AU (1) AU737865B2 (en)
BR (1) BR9712128A (en)
CA (1) CA2267179A1 (en)
IL (1) IL129177A0 (en)
NO (1) NO991465L (en)
WO (1) WO1998013007A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6169078B1 (en) 1998-05-12 2001-01-02 University Of Florida Materials and methods for the intracellular delivery of substances
TWI242000B (en) * 1998-12-10 2005-10-21 Univ Southern California Reversible aqueous pH sensitive lipidizing reagents, compositions and methods of use
GB0103877D0 (en) * 2001-02-16 2001-04-04 King S College London Novel Drug Delivery system
US20050054612A1 (en) * 2003-09-08 2005-03-10 Monahan Sean D. Delivery by labile hydrophobic modification of drugs
JP2008500275A (en) * 2003-12-31 2008-01-10 セントカー・インコーポレーテツド Novel recombinant protein having an N-terminal free thiol
JP2010508271A (en) 2006-10-27 2010-03-18 ウェイ‐チャン シェン Lipidated interferon and uses thereof
US20080226707A1 (en) * 2007-03-05 2008-09-18 Jill Helms WNT compositions and methods of use thereof
WO2009105783A1 (en) * 2008-02-21 2009-08-27 Dermacare Neuroscience Institute Cosmetic and dermatological formulations of mntf peptides
EP2961733B1 (en) * 2013-02-28 2021-01-13 Tufts University Disulfide compounds for delivery of pharmaceutical agents
US20160082126A1 (en) 2013-05-13 2016-03-24 Tufts University Nanocomplexes for delivery of saporin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5907030A (en) * 1995-01-25 1999-05-25 University Of Southern California Method and compositions for lipidization of hydrophilic molecules
JP4651753B2 (en) * 1996-06-25 2011-03-16 ペプスキャン システムズ ベー．フェー． Vaccine consisting of carrier-bound antigen with labile binding

Also Published As

Publication number Publication date
EP1023316A2 (en) 2000-08-02
CN1235594A (en) 1999-11-17
AU4596797A (en) 1998-04-17
NO991465D0 (en) 1999-03-25
KR100691315B1 (en) 2007-03-12
JP2002515883A (en) 2002-05-28
EP1023316A4 (en) 2004-06-09
WO1998013007A2 (en) 1998-04-02
AU737865B2 (en) 2001-09-06
IL129177A0 (en) 2000-02-17
CN1127477C (en) 2003-11-12
KR20000048608A (en) 2000-07-25
NO991465L (en) 1999-05-10
BR9712128A (en) 2000-12-12
CA2267179A1 (en) 1998-04-02

Similar Documents

Publication Publication Date Title
EA199700143A1 (en) METHOD AND COMPOSITION FOR LIPIDIZATION OF HYDROPHIL MOLECULES
Maroudas et al. Aggrecan turnover in human articular cartilage: use of aspartic acid racemization as a marker of molecular age
WO2000064484A3 (en) Conjugate having a cleavable linkage for use in a liposome
Yang et al. A cell-penetrating peptide conjugated carboxymethyl-β-cyclodextrin to improve intestinal absorption of insulin
WO1998013007A8 (en) Methods and compositions for lipidization of hydrophilic molecules
WO1997029779A3 (en) EGF-Genistein conjugates for the treatment of cancer
AU4835396A (en) Composition containing nucleic acids, preparation and use
IL122472A (en) Compositions of fgf9 as a specific ligand for fgfr3 and uses thereof
WO1999048536A3 (en) Delivery of long lasting therapeutic agents by forming covalent attachments in vivo
CA2491054A1 (en) Compositions of hyaluronic acid and methods of use
ES8507573A1 (en) Hyaluronic acid fractions having pharmaceutical activity, methods for preparation thereof, and pharmaceutical compositions containing the same.
IE60704B1 (en) Cosmetic and dermatological compositions including an extract of marianum sillybum rich in sillymarine associated with essential fatty acids
BR0211071A (en) Polypeptide conjugate showing g-csf activity, method for preparing a g-csf conjugate, composition, method for treating a mammal suffering from an insufficient neutrophilic level, and use of the polypeptide conjugate
CA2355774A1 (en) Fibre blend for enteral composition
Fujii et al. Biochemical properties of collagen from ligaments and periarticular tendons of the human knee
NZ501386A (en) Collagen from fish skin
CA2301799A1 (en) Novel conjugates of opioids and endogenous carriers
Park et al. Alternative approaches to oral controlled drug delivery: bioadhesives and in-situ systems
DE69805334T2 (en) DERIVATIVES OF VITAMIN E
KR100273389B1 (en) Use of Oligosaccharides for the Prevention and Treatment of Tissue Aging
EA200100652A1 (en) COMPOUND (VARIANTS) AND ITS FORMATION METHOD, METHOD FOR ABSORPTION ENHANCEMENT OF CELLULAR CONNECTION amino group method of prolonging retention in the blood and tissues of mammals biologically active compounds with an amino group AND METHOD OF DELIVERY IN inside of the cell, the pharmaceutical composition, the pharmaceutical preparations
TW286320B (en)
Ito et al. Correlation between prevention of cataract development by disulfiram and fates of selenium in selenite-treated rats.
EP0506976A1 (en) Combination of hyaluronic acid with medicinal ingredient and production thereof
WO2000070665A3 (en) Long lasting anti-angiogenic peptides

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 97199191.X

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: PAT. BUL. 13/98, UNDER (30) REPLACE THE EXISTING TEXT BY "08/721306 26.09.96 US 60/049499 13.06.97 US"

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
COP Corrected version of pamphlet

Free format text: PAGES 1/11-11/11, DRAWINGS, REPLACED BY NEW PAGES 1/13-13/13; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

WWE Wipo information: entry into national phase

Ref document number: 1019997002543

Country of ref document: KR

ENP Entry into the national phase

Ref document number: 2267179

Country of ref document: CA

Ref document number: 2267179

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: PA/a/1999/002914

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 1997944483

Country of ref document: EP

AK Designated states

Kind code of ref document: C1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

D17 Declaration under article 17(2)a
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1019997002543

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 1997944483

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1019997002543

Country of ref document: KR